MedTrace Logo

Evaluating Pharmacokinetics and Pharmacodynamics of Jusline

NCT00532766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-09-26

No results posted yet for this study

Summary

To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.

Conditions

  • Healthy

Interventions

DRUG

Jusline

Sponsors & Collaborators

  • King Saud University

    lead OTHER

Principal Investigators

  • Khalid A Al-Rubeaan, MD · College of Medicine, King Saud University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Completion
2007-02-28

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00532766 on ClinicalTrials.gov